Move over, Big Pharma. Big Biotech is coming for you.
As drug developers and investors from around the world gather in San Francisco this week for the annual BIO International Convention, a new look at the biotech industry shows the biggest players are starting to behave more and more like pharmaceutical giants.
There are 17 biotech companies in the US that generate more than $500 million per year in revenue. And they’re increasingly focused on buying innovative new products through mergers and acquisitions, rather than developing them in house, according to a report from EY (formerly Ernst & Young) released Monday.
About the Author Reprints
Currently, we are organizing Annual Summit on Cell Signaling and Cancer Therapy 2017 during September 27-28, 2017 in Chicago, Illinois, USA. We would like to notify you about exhibitor slots at our upcoming annual conference.
Why to Sponsor/exhibit at Cell Signaling 2017?
Unique platform for business promotion
Global Networking Opportunities
Best Visibility from your target audience, Globally
Best Economic Advertisement platform
Extreme Social Media Promotion
Group Discounts Available! 40%
Please feel free to contact me for further queries
Regards,
Name: Delisa Brook
email: [email protected]
Telephone: ( Respective International Ext) and +1-888-843-8169